Skip to main content

Educational videos

Filter by

Enterra Therapy Patient Selection

Selecting the right patients for Enterra Therapy is crucial for optimal outcomes. Our educational videos guide you through the criteria and considerations for patient selection, ensuring that you have the knowledge to identify candidates who may benefit most from this advanced gastroparesis treatment.

Best Practices in Patient Selection and Management of Gastroparesis Patients

0:29:27
Watch recording
IMPORTANT SAFETY INFORMATION

Enterra Therapy for treatment of chronic, resistant to medication nausea and vomiting associated with gastroparesis caused by diabetes or an unknown origin in patients aged 18 to 70 years: patients should always discuss potential risks and benefits of the device with their physician.

HUMANITARIAN DEVICE

Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. What does this mean?